11-123634162-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_001040151.2(SCN3B):c.629C>T(p.Ala210Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000175 in 1,613,600 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001040151.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN3B | NM_001040151.2 | c.629C>T | p.Ala210Val | missense_variant | 6/7 | ENST00000299333.8 | NP_001035241.1 | |
SCN3B | NM_018400.4 | c.629C>T | p.Ala210Val | missense_variant | 5/6 | NP_060870.1 | ||
SCN3B | XM_011542897.3 | c.629C>T | p.Ala210Val | missense_variant | 6/7 | XP_011541199.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN3B | ENST00000299333.8 | c.629C>T | p.Ala210Val | missense_variant | 6/7 | 1 | NM_001040151.2 | ENSP00000299333.3 |
Frequencies
GnomAD3 genomes AF: 0.000533 AC: 81AN: 152064Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000370 AC: 93AN: 251368Hom.: 0 AF XY: 0.000368 AC XY: 50AN XY: 135870
GnomAD4 exome AF: 0.000138 AC: 202AN: 1461418Hom.: 0 Cov.: 31 AF XY: 0.000147 AC XY: 107AN XY: 727030
GnomAD4 genome AF: 0.000532 AC: 81AN: 152182Hom.: 1 Cov.: 32 AF XY: 0.000874 AC XY: 65AN XY: 74400
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 30, 2024 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; In silico analysis indicates that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868) - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 03, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Brugada syndrome 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at